Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.09
-0.10 (-3.13%)
At close: Aug 15, 2025, 3:59 PM
3.08
-0.32%
After-hours: Aug 15, 2025, 07:16 PM EDT

Ekso Bionics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
n/a 8.05M 6.49M 8.29M 5.88M 8.8M 8.64M 9.94M 13.31M 16.28M 20.52M 29.18M 31.91M 36.18M 40.41M 43.44M 45.94M 49.54M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
362K 357K 433K 531K 435K 440K 392K 279K 332K 258K 231K 224K 128K 141K 164K 125K 163K 235K
Receivables
4.53M 6.46M 7.24M 6.96M 6.52M 5.77M 5.64M 5.87M 5.05M 4.83M 4.63M 3.4M 3.34M 3.35M 4.66M 3.12M 2.76M 2.28M
Inventory
5.44M 4.96M 4.57M 5.03M 4.97M 5.11M 5.05M 5.49M 5.6M 5.66M 5.19M 3.51M 3.27M 2.77M 2.24M 1.75M 1.95M 2.15M
Other Current Assets
6M 8.65M 541K 779K 1.26M 838K 875K 1.06M 759K 831K 700K 668K 796K 829K 485K 788K 648K 636K
Total Current Assets
15.97M 20.07M 18.84M 21.07M 18.64M 20.52M 20.21M 22.36M 24.72M 27.6M 31.04M 36.75M 39.32M 43.12M 47.8M 49.1M 51.3M 54.6M
Property-Plant & Equipment
2.17M 2.14M 2.37M 2.52M 2.74M 2.75M 3M 3.14M 3.45M 3.68M 3.99M 2.33M 1.07M 978K 1.21M 1.51M 1.51M 1.66M
Goodwill & Intangibles
4.67M 4.75M 5.01M 5.09M 5.17M 5.25M 5.32M 5.4M 5.48M 5.57M 5.65M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
7.19M 7.24M 7.81M 8.14M 8.34M 8.44M 8.71M 8.82M 9.27M 9.51M 9.87M 2.56M 1.2M 1.12M 1.37M 1.63M 1.68M 1.9M
Total Assets
23.17M 27.31M 26.65M 29.21M 26.98M 28.96M 28.92M 31.18M 33.99M 37.1M 40.9M 39.31M 40.52M 44.24M 49.17M 50.73M 52.97M 56.5M
Account Payables
1.45M 2M 1.55M 1.81M 2.13M 1.88M 1.85M 2.5M 3.15M 3.04M 3.15M 2.39M 2.04M 2.94M 3.11M 1.31M 1.43M 1.65M
Deferred Revenue
1.81M 1.91M 1.96M 2.04M 1.93M 2.03M 1.99M 1.64M 1.29M 1.3M 1.12M 1.06M 1.14M 1.11M 1.22M 1.29M 1.42M 1.49M
Short-Term Debt
1.7M 1.68M 1.25M 1.25M 430K 1.25M 1.61M 1.6M 3.29M 2.62M 2.65M 244K 51K 97K 229K 372K 514K 814K
Other Current Liabilities
1.76M 2.97M 668K 561K 2.67M 1.02M 486K 406K 472K 976K 188K 4.2M 484K 404K 110K -366K -682K 416K
Total Current Liabilities
6.71M 8.55M 7.54M 7.51M 7.7M 7.31M 8.12M 7.83M 10.13M 9.54M 9.2M 7.86M 4.82M 5.97M 6.86M 4.67M 4.68M 5.98M
Long-Term Debt
3.69M 3.94M 3.85M 4.11M 4.35M 4.59M 4.83M 5.88M 4.21M 3.53M 4.85M 1.17M 2M 1.99M 1.99M 1.99M 1.99M 2.36M
Other Long-Term Liabilities
1.83M 2.12M 182K 200K 194K 255K 471K -672K -697K 384K -713K -527K 720K 1.71M 1.62M 3.56M 4.68M 5.44M
Total Long-Term Liabilities
5.52M 6.07M 6.41M 6.83M 7.22M 7.59M 8.2M 8.09M 6.05M 6.28M 6.26M 2.84M 3.97M 4.79M 5.09M 7M 8.2M 9.55M
Total Liabilities
12.24M 14.62M 13.95M 14.34M 14.93M 14.91M 16.31M 15.93M 16.18M 15.82M 15.46M 10.7M 8.79M 10.76M 11.95M 11.67M 12.88M 15.53M
Total Debt
5.39M 5.62M 5.98M 6.35M 6.69M 6.84M 7.17M 7.48M 7.5M 7.5M 7.5M 3.41M 2.16M 2.09M 2.22M 2.36M 2.5M 3.72M
Common Stock
36K 28K 22K 22K 19K 18K 15K 14K 14K 13K 13K 13K 13K 13K 13K 13K 13K 13K
Retained Earnings
-256.3M -253.59M -250.47M -247.06M -244.99M -242.57M -239.15M -235.93M -232.57M -228.34M -223.95M -220.77M -216.47M -213.49M -208.87M -206M -204.05M -202.77M
Comprehensive Income
-683K 424K 957K 12K 539K 447K 156K 733K 359K 369K 563K 1.49M 834K 195K -17K -246K -507K -382K
Shareholders Equity
10.93M 12.69M 12.71M 14.87M 12.06M 14.05M 12.61M 15.26M 17.81M 21.28M 25.44M 28.61M 31.73M 33.49M 37.22M 39.06M 40.1M 40.98M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a